[
    [
        {
            "time": "2021-04-20",
            "original_text": "东吴证券----金域医学2020年年报及2021年一季报点评：业绩高增长，股权激励体现公司信心，ICL龙头发展提速【公司研究】",
            "features": {
                "keywords": [
                    "金域医学",
                    "年报",
                    "一季报",
                    "业绩高增长",
                    "股权激励",
                    "ICL龙头"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "东吴证券----金域医学2020年年报及2021年一季报点评：业绩高增长，股权激励体现公司信心，ICL龙头发展提速【公司研究】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "一季度多只医药股获明星基金增持",
            "features": {
                "keywords": [
                    "医药股",
                    "明星基金",
                    "增持"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一季度多只医药股获明星基金增持",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "医疗板块持续拉升，凯普生物一季报利润暴涨8倍涨超7.6%",
            "features": {
                "keywords": [
                    "医疗板块",
                    "凯普生物",
                    "一季报",
                    "利润暴涨"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗板块持续拉升，凯普生物一季报利润暴涨8倍涨超7.6%",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "高瓴资本概念股普遍强势，甘李、泰格、金域、国瓷材料、健帆生物大涨",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "金域医学",
                    "大涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股普遍强势，甘李、泰格、金域、国瓷材料、健帆生物大涨",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "金域医学去年净利15亿销售费近10亿 一季度两基金减仓",
            "features": {
                "keywords": [
                    "金域医学",
                    "净利",
                    "销售费",
                    "基金减仓"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学去年净利15亿销售费近10亿 一季度两基金减仓",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-20",
            "original_text": "受益于新冠业务收入增长，金域医学一季度业绩大增超10倍",
            "features": {
                "keywords": [
                    "金域医学",
                    "新冠业务",
                    "业绩大增"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "受益于新冠业务收入增长，金域医学一季度业绩大增超10倍",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]